Volta Labs, Inc.

Volta Labs presents significant red flags for defense tech investment. The company description ('unlocking utility of genomics') has no apparent connection to the stated industry tag ('defense-autonomy'), suggesting either misclassification or pivoting without clear articulation. YC Winter 2019 acceptance provides minimal validation in a defense context, and no named founders, defense partnerships, government contracts, or customer traction are evident. Without clarity on team backgrounds, defensible technical differentiation in autonomy, or alignment with DoD priorities, this appears to be a life sciences company with tenuous or speculative defense application.